Samsung Medical Center

NCT07776054

Phase 4Recruiting2024200 people20 Aug 2026clinicaltrials.gov

NCT06763744

Phase 4Not yet recruiting20253,000 people8 Jan 2025clinicaltrials.gov

NCT06552559

Phase 1/2Recruiting202437 people14 Aug 2024clinicaltrials.gov

NCT05845424

Phase 4Recruiting20236,000 people6 May 2023clinicaltrials.gov

NCT05509374

Phase 2Status unknown202133 people22 Aug 2022clinicaltrials.gov

NCT05483894

Phase 2Status unknown202236 people2 Aug 2022clinicaltrials.gov

NCT04921189

CollaboratorPhase 2Completed2021160 people10 Jun 2021clinicaltrials.gov

NCT04792749

Phase 3Status unknown202177 people11 Mar 2021clinicaltrials.gov

NCT04546828

Phase 2Withdrawn20210 people14 Sept 2020clinicaltrials.gov

NCT04277845

Phase 2Status unknown202049 people20 Feb 2020clinicaltrials.gov

NCT04014803

Phase 4Recruiting20203,500 people10 Jul 2019clinicaltrials.gov

NCT03822520

Phase 1Completed201728 people30 Jan 2019clinicaltrials.gov

NCT03585998

Phase 2Status unknown201851 people13 Jul 2018clinicaltrials.gov

NCT03487133

Phase 2Completed201732 people3 Apr 2018clinicaltrials.gov

NCT03377400

Phase 2Status unknown201740 people19 Dec 2017clinicaltrials.gov

NCT03243851

CollaboratorPhase 2Completed201681 people9 Aug 2017clinicaltrials.gov

NCT03169985

Phase 4Active, not recruiting2017280 people30 May 2017clinicaltrials.gov

NCT03119012

Phase 4Terminated201725 people18 Apr 2017clinicaltrials.gov

NCT03086291

Phase 1Status unknown20189 people22 Mar 2017clinicaltrials.gov

NCT03061630

Phase 2Status unknown201749 people23 Feb 2017clinicaltrials.gov

Quantitative FP-CIT PET analysis of dopaminergic degeneration in isolated REM sleep behavior disorder and early Parkinson's disease

28 Sept 2026api.crossref.org